No definition available.
Respiratory conditions due to other external agents
EFO MESH Endpoint Browser PheWeb
J10_RESPCONDEXT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
695 |
4. Check minimum number of eventsNone |
695 |
5. Include endpointsNone |
695 |
6. Filter based on genotype QC (FinnGen only) |
695 |
Control definitions (FinnGen only)
- Control exclude
- J10_EXTERLUNG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J60-J70
- Name in latin
- Morbositates respiratoriae ex aliis agentibus externis
Similar endpoints
↥List of similar endpoints to
Respiratory conditions due to other external agents
based on the number of shared cases.
Similar with more cases:
- Lung diseases due to external agents
- Diagnoses used for exclusion with ILD
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5135 | 2989 | 2077 |
| Only index persons | 3638 | 2249 | 1389 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.09 | 0.06 |
| Only index persons | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 69.92 | 70.17 | 69.46 |
| Only index persons | 67.98 | 67.98 | 67.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 695 | 402 | 293 |
| Unadjusted period prevalence (%) | 0.13 | 0.14 | 0.13 |
| Median age at first event (years) | 66.68 | 63.64 | 70.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 631
- Matched controls
- 6308
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
+∞
262.3
233
*
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
+∞
251.3
224
*
H02AB06
ATC
prednisolone; systemic
7.0
102.5
500
2217
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
17.5
97.4
160
120
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.9
71.3
203
404
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
70.3
432
2015
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.8
67.1
171
287
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.6
64.7
306
1075
H02AB02
ATC
dexamethasone; systemic
6.3
61.9
188
398
A03FA01
ATC
metoclopramide; systemic, rectal
4.7
61.8
270
866
TGC00
NOMESCO Finland
Bronchial lavation
21.7
58.6
87
46
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
+∞
57.1
54
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
57.0
169
343
A04AA02
ATC
granisetron; systemic, transdermal
7.8
52.4
130
203
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
+∞
51.8
49
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
10.6
49.4
100
110
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.6
48.1
135
250
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.3
46.8
84
72
115
Kela drug reimbursment
Breast cancer
5.8
45.7
143
303
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
40.0
38
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.8
39.1
105
180
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
37.6
288
1332
JN4BD
NOMESCO Finland
Extensive body CT
4.5
37.6
150
408
GD1AD
NOMESCO Finland
Thorax CT examination
8.6
37.3
84
110
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.3
34.2
114
254
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.7
34.1
71
81
JN4AD
NOMESCO Finland
Body CT examination
5.3
34.0
113
251
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.9
33.8
63
58
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
33.6
81
118
L02BG04
ATC
letrozole; oral
5.8
33.3
101
201
130
Kela drug reimbursment
Malignant tumour
4.7
33.1
123
308
J01MA12
ATC
levofloxacin; systemic
3.3
32.2
200
779
ZX080
NOMESCO Finland
Image guided radiotherapy
12.7
32.0
58
50
N02AA05
ATC
oxycodone; systemic
3.5
31.8
173
607
A02BC02
ATC
pantoprazole; systemic
2.9
31.8
479
3266
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
30.3
307
1631
HA1AA
NOMESCO Finland
X-ray mammography
4.7
30.2
112
278
ZX070
NOMESCO Finland
Intensity modified radiotherapy
11.7
29.9
56
52
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.1
29.8
76
120
R50.9
ICD-10 Finland
Fever, unspecified
3.6
29.3
151
505
R06.0
ICD-10 Finland
Dyspnoea
2.8
28.8
237
1101
WZC30
NOMESCO Finland
Teaching
3.7
28.5
142
461
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
9.0
28.2
61
74
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.0
27.8
80
148
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
18.2
26.5
41
24
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
25.4
128
417
J70.9
ICD-10 Finland
Respiratory conditions due to unspecified external agent
+∞
25.2
24
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.3
24.8
45
39
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
24.8
88
207
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
24.7
87
203
C03CA01
ATC
furosemide; systemic
2.4
23.6
280
1558
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
23.2
74
155
WF003
NOMESCO Finland
Adjuvant radiotherapy
6.6
23.0
61
101
L03AA14
ATC
lipegfilgrastim; parenteral
10.4
22.9
45
46
A04AA55
ATC
palonosetron, combinations; systemic
8.1
22.8
52
69
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
24.0
22.8
32
14
L03AA13
ATC
pegfilgrastim; parenteral
6.1
22.4
63
113
B01AB10
ATC
tinzaparin; parenteral
4.4
22.0
84
212
ZXE00
NOMESCO Finland
One hour or less
2.3
21.7
300
1777
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
5.9
21.6
62
114
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.6
21.6
57
94
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
4.4
21.4
81
203
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
21.4
189
887
PJA12
NOMESCO Finland
Sentinel node biopsy
3.8
21.3
96
282
JN4CD
NOMESCO Finland
Very extensive body CT
5.8
20.4
59
110
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
19.6
20.1
30
16
Z51.5
ICD-10 Finland
Palliative care
4.1
19.9
81
217
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
19.8
123
461
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.2
19.6
44
57
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.1
19.5
54
95
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
4.5
19.1
70
170
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.0
19.1
63
137
A04AA01
ATC
ondansetron; systemic, rectal
4.3
18.3
70
177
HAB40
NOMESCO Finland
Wedge excision of mammary gland
4.3
18.0
69
175
WF004
NOMESCO Finland
Palliative radiotherapy
8.9
17.9
38
45
TGD00
NOMESCO Finland
Needle biopsy of lung
37.9
17.7
22
6
XW000
NOMESCO Finland
Bone marrow biopsy
5.1
17.6
56
117
WF002
NOMESCO Finland
Radical radiotherapy
4.5
17.2
62
148
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
17.1
140
619
J01MA14
ATC
moxifloxacin; systemic
3.4
16.9
87
284
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.4
16.8
40
57
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
16.8
93
319
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.5
16.6
32
32
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
23.8
16.5
23
10
NK6AN
NOMESCO Finland
Total body bone isotope imaging
6.1
16.2
44
76
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.0
16.0
66
179
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.9
15.9
105
405
C01BD01
ATC
amiodarone; systemic
5.6
15.4
45
85
ZXD05
NOMESCO Finland
Urgent procedure
2.1
15.3
220
1271
M05BX04
ATC
denosumab; parenteral
3.9
15.2
65
182
WW500
NOMESCO Finland
Blood transfusion
4.8
15.2
51
113
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
20.7
15.2
22
11
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
15.0
267
1682
A02BC01
ATC
omeprazole; systemic
2.1
15.0
219
1273
HAC20
NOMESCO Finland
Total mastectomy
4.1
14.7
59
156
A04AD12
ATC
aprepitant; systemic
7.0
14.7
36
54
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.4
14.4
53
129
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
8.5
14.4
31
38
L03AA02
ATC
filgrastim; parenteral
6.5
14.3
37
60
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
14.3
309
2085
B01AB05
ATC
enoxaparin; parenteral
2.0
14.3
231
1393
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.8
13.9
47
105
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
13.9
169
903
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
4.5
13.7
49
116
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
6.8
13.7
34
52
N03AX16
ATC
pregabalin; oral
2.1
13.7
178
980
5088A
ICD-9 Finland
Respiratory conditions due to other and unspecified external agents, Respiratory conditions due to other specified external agents[MORBI ORGANORUM RESPIRATIONIS E PHARMACO]
+∞
13.6
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
13.5
97
394
C50.99
ICD-10 Finland
Breast, unspecified
5.3
13.4
41
82
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
8.4
13.4
29
36
L02BA01
ATC
tamoxifen; oral
4.5
13.3
47
110
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
13.3
75
260
C07AB07
ATC
bisoprolol; oral
1.9
13.3
346
2473
L02BG06
ATC
exemestane; oral
8.2
13.2
29
37
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
12.5
13.2
23
19
M04AA01
ATC
allopurinol; systemic
2.4
13.1
120
557
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
11.9
12.9
23
20
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.6
12.7
22
18
XX1XN
NOMESCO Finland
Other isotope examination
11.3
12.6
23
21
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
13.5
12.5
21
16
L01CA04
ATC
vinorelbine; systemic
13.5
12.5
21
16
L02BG03
ATC
anastrozole; oral
6.7
12.5
31
48
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
7.4
12.4
29
41
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
12.4
127
621
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
5.8
12.2
34
61
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.0
12.1
49
131
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
7.5
12.1
28
39
N05CF01
ATC
zopiclone; oral
1.9
12.0
242
1562
J70.8
ICD-10 Finland
Respiratory conditions due to other specified external agents
+∞
11.5
11
*
X76
ICPC
Malignant neoplasm breast female
6.2
11.5
30
50
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.2
11.4
27
39
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
11.3
81
328
ZX120
NOMESCO Finland
Intravenous
2.6
11.3
86
359
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.9
11.3
22
23
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.2
11.3
43
109
WX402
NOMESCO Finland
General anaesthesia
2.3
11.3
118
581
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
35.7
11.3
14
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
9.1
10.8
22
25
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
9.1
10.8
22
25
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
10.8
182
1094
N02AX02
ATC
tramadol; systemic, rectal
1.8
10.8
292
2061
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
10.8
92
411
ED1AA
NOMESCO Finland
Mandipular X-ray examination
61.0
10.7
12
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
4.4
10.6
38
91
R03AC02
ATC
salbutamol; inhalant
1.8
10.6
322
2348
N02AA01
ATC
morphine; systemic, rectal
8.7
10.6
22
26
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.7
10.6
26
40
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
4.9
10.4
33
70
R05
ICD-10 Finland
Cough
2.1
10.3
137
749
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
19.2
10.3
15
8
J01CA04
ATC
amoxicillin; systemic
1.9
10.3
484
4031
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
10.2
34
76
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.3
10.1
30
59
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
40.7
10.0
12
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
6.1
9.9
26
44
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
12.4
9.9
17
14
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
9.8
56
196
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
9.8
144
819
XG410
NOMESCO Finland
Flow-volume spirometry
3.9
9.8
39
104
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
9.7
82
361
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.0
9.7
21
27
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
9.7
76
322
N02BE01
ATC
paracetamol; systemic, rectal
2.0
9.6
537
4678
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
9.5
63
244
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.6
9.4
16
13
5088X
ICD-9 Finland
Respiratory conditions due to other and unspecified external agents, Respiratory conditions due to other specified external agents[MORBI ORGANORUM RESP CAUSA EXT ALIA DEFINITA]
+∞
9.4
9
*
L04AX01
ATC
azathioprine; systemic
3.9
9.4
38
103
M05BA04
ATC
alendronic acid; oral
2.4
9.4
78
344
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
9.1
117
628
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
15.9
9.1
14
9
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
37.2
9.0
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
9.0
109
573
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.5
9.0
70
298
R03BB04
ATC
tiotropium bromide; inhalant
2.3
8.9
85
402
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.8
200
1312
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
6.5
8.8
22
35
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
9.7
8.8
17
18
A06AD11
ATC
lactulose; oral
2.0
8.8
117
637
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.8
8.7
36
100
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
6.3
8.7
22
36
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.9
8.7
23
40
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.9
8.7
23
40
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
8.6
220
1496
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.9
8.6
27
57
JN6AD
NOMESCO Finland
CT of torso and neck
8.4
8.6
18
22
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.7
8.6
28
62
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
8.5
84
401
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
8.4
79
367
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
8.0
8.4
18
23
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
8.0
8.4
18
23
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.9
8.4
50
182
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
13.0
8.4
14
11
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
10.9
8.3
15
14
J01DB01
ATC
cefalexin; oral
1.7
8.3
483
4116
R04.2
ICD-10 Finland
Haemoptysis
3.6
8.3
36
104
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
8.3
86
422
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.2
8.3
30
74
C50
ICD-10 Finland
Malignant neoplasm of breast
4.5
8.2
28
65
L04AA13
ATC
leflunomide; oral
4.5
8.2
28
65
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
4.8
8.2
26
56
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.1
252
1806
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
17.4
8.1
12
7
R84
ICPC
Malignant neoplasm bronchus/lung
17.4
8.1
12
7
J01FF01
ATC
clindamycin; systemic
1.8
8.1
168
1068
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
10.2
8.1
15
15
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.8
8.0
165
1047
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
7.9
51
195
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.7
7.9
51
196
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
4.4
7.8
27
64
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.1
7.8
23
46
WX892
NOMESCO Finland
Monitored bed care
2.4
7.8
63
275
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
7.7
274
2026
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.8
7.7
31
85
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
8.2
7.6
16
20
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
8.2
7.6
16
20
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
18.6
7.6
11
6
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
18.6
7.6
11
6
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.3
7.6
22
43
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
7.6
53
213
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
7.5
115
659
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
7.5
36
113
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
6.6
7.5
18
28
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.4
7.4
21
40
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.1
7.4
19
32
J01AA02
ATC
doxycycline; systemic
1.7
7.3
486
4197
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
7.3
160
1033
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
6.4
7.3
18
29
J96.1
ICD-10 Finland
Chronic respiratory failure
4.2
7.3
26
64
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
15.9
7.2
11
7
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
30.4
7.2
9
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
30.4
7.2
9
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
20.3
7.1
10
5
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
7.1
171
1129
J96.0
ICD-10 Finland
Acute respiratory failure
5.4
7.1
20
38
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
12.2
7.1
12
10
A02BC05
ATC
esomeprazole; systemic
1.6
7.1
254
1870
SPAT1263
SPAT
Sampling
1.6
7.1
261
1935
J01DA01
ATC
[U] cefalexin; systemic
1.6
7.1
373
3021
Z31.5
ICD-10 Finland
Genetic counselling
3.4
7.0
32
97
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
7.0
87
460
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
3.6
7.0
30
87
L04AA06
ATC
mycophenolic acid; systemic
5.3
7.0
20
39
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
5.3
7.0
20
39
B01AA03
ATC
warfarin; systemic
1.7
7.0
154
995
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.1
6.8
25
63
WF099
NOMESCO Finland
Other radiotherapy
9.4
6.8
13
14
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
40.5
6.8
8
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
16.9
6.8
10
6
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
16.9
6.8
10
6
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
6.7
43
165
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.3
6.7
19
37
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
6.0
6.6
17
29
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.5
6.6
49
203
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
70.5
6.4
7
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
6.4
92
515
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.6
6.4
15
23
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
4.3
6.4
22
53
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
5.3
6.4
18
35
WX722
NOMESCO Finland
PEEP
3.0
6.4
36
126
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
8.3
6.4
13
16
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
18.2
6.3
9
5
J80
ICD-10 Finland
Adult respiratory distress syndrome
18.2
6.3
9
5
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
7.1
6.2
14
20
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
6.2
94
535
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.4
6.2
15
24
Z3231
NOMESCO Finland
Registered nurse
1.6
6.2
172
1182
I50.0
ICD-10 Finland
Congestive heart failure
2.1
6.2
65
323
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.8
6.1
13
17
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
12.7
6.1
10
8
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
6.1
33
115
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
10.1
6.0
11
11
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
6.1
6.0
15
25
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
82
56
16.47
93.61
1.7
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
109
125
10.16
89.53
1.9
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
110
131
9.79
87.77
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
77
58
14.81
83.12
2.0
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
86
78
12.44
82.97
1.8
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
92
95
11.01
81.32
1.7
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
92
98
10.67
79.51
2.0
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
107
141
8.79
78.55
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
82
78
11.79
76.56
1.7
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61
45
14.76
66.37
1.9
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
74
76
10.78
65.36
1.7
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
52
29
19.30
65.20
1.9
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
77
84
10.18
65.13
2.4
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
77
85
10.06
64.56
1.7
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
51
28
19.58
64.39
1.9
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
35
16.31
61.13
1.8
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
366
1664
3.53
59.02
6.5
4.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
250
928
3.65
54.77
5.3
3.2
mmol/l
0.8
0.8
0.62
242
854
(3030905) Polymorphonuclear cells [#/volume] in Blood
75
100
8.29
54.04
3.2
2.7
e9/l
4.4
4.5
0.19
75
100
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
76
105
8.00
53.13
3.7
3.0
%
61.9
59.3
0.66
76
105
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
89
8.63
52.42
3.8
7.8
iu/ml
504.6
156.4
—
9
15
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
170
500
4.18
51.97
7.0
3.5
mmol/l
1.2
1.2
0.01
162
434
(42870588) Differential panel, method unspecified - Blood
382
1888
3.27
51.78
9.2
5.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
80
121
7.34
51.61
5.1
3.7
mmol/l
2.7
2.6
0.03
65
82
(3010421) pH of Blood
87
145
6.72
51.25
5.2
3.5
ph
7.4
7.4
3.59
80
118
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
104
209
5.68
50.57
2.8
2.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
77
115
7.41
50.22
4.0
3.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
66
84
8.58
49.33
1.4
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
202
700
3.66
48.43
2.4
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
32
12
27.91
46.68
1.8
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
31
11
29.45
46.04
1.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
197
696
3.55
45.56
2.4
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
181
607
3.68
45.31
4.7
3.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
359
1814
3.03
45.02
7.2
3.7
ph
7.4
7.4
1.40
142
339
(3036481) Cortisol [Moles/volume] in Serum or Plasma
159
492
3.89
44.77
3.2
2.0
nmol/l
357.6
375.3
0.41
153
442
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
244
994
3.24
44.68
2.6
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
440
2509
3.05
43.86
10.2
5.5
%
0.6
0.7
2.85
425
2320
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
106
245
4.93
43.74
2.3
1.9
ug/l
3.8
2.8
0.17
98
216
(3001604) Monocytes [#/volume] in Blood
465
2737
3.11
43.70
9.6
5.3
e9/l
0.6
0.6
2.75
438
2339
(3006315) Basophils [#/volume] in Blood
466
2753
3.10
43.37
9.6
5.3
e9/l
0.0
0.0
0.10
438
2367
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
32
15
22.31
42.94
1.2
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
446
2585
3.02
42.73
10.8
5.8
%
8.8
8.8
0.07
434
2402
(4035726)
164
534
3.71
42.70
1.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
469
2796
3.08
42.64
10.1
5.4
e9/l
1.6
1.9
5.31
445
2443
(3013650) Neutrophils [#/volume] in Blood by Automated count
512
3213
3.25
42.35
18.7
8.8
e9/l
4.4
4.1
2.55
489
2814
(3006504) Eosinophils/100 leukocytes in Blood
444
2577
3.00
42.24
10.4
5.5
%
2.3
2.8
4.95
431
2385
(3002030) Lymphocytes/100 leukocytes in Blood
450
2633
3.01
42.14
10.5
5.7
%
22.5
27.0
14.52
437
2428
(3013115) Eosinophils [#/volume] in Blood
472
2848
3.05
41.51
10.0
5.6
e9/l
0.2
0.2
1.78
446
2488
(40767503) Oxygen content in Capillary blood by calculation
69
116
6.49
40.10
3.4
2.3
%
16.0
15.8
0.11
30
59
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
36
26
14.55
39.33
1.8
2.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
437
2595
2.84
38.38
10.0
5.5
%
61.9
57.8
9.48
424
2410
(40761536) Microorganisms panel - Urine sediment
143
465
3.61
36.93
4.5
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
180
680
3.22
36.54
5.1
3.8
u/l
247.6
254.2
0.18
173
638
(3011412) CD3 cells [#/volume] in Blood
39
37
11.11
36.05
1.9
2.0
e9/l
0.8
1.1
0.99
34
20
(40760892) CBC W Ordered Manual Differential panel - Blood
246
1118
2.86
35.81
7.4
4.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
143
475
3.53
35.66
4.4
3.8
%
1.1
0.9
0.60
75
147
(3002179) Metamyelocytes/100 leukocytes in Blood
132
427
3.58
34.20
4.3
3.9
%
0.8
0.4
1.42
63
105
(3023419) Bacteria identified in Sputum by Culture
52
79
7.03
33.17
2.2
2.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
50
74
7.20
32.66
2.6
2.1
%
89.2
89.2
0.01
50
74
(3025159) Blasts/100 leukocytes in Blood
128
423
3.48
31.97
4.2
4.0
%
0.0
0.9
0.52
64
112
(3021440) Promyelocytes/100 leukocytes in Blood
132
446
3.42
31.83
4.4
4.0
%
0.2
0.1
0.22
71
133
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
470
3065
2.65
31.51
12.1
5.9
umol/l
9.3
11.3
5.69
455
2895
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
458
2984
2.57
30.19
10.2
6.4
mmol/l
1.2
1.2
0.03
327
2499
(44790049)
42
56
7.92
30.01
1.7
1.6
—
—
—
0
0
(44806118)
42
56
7.92
30.01
1.7
1.6
—
—
—
0
0
(44790047)
42
56
7.92
30.01
1.7
1.6
—
—
—
0
0
(44790048)
42
56
7.92
30.01
1.7
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
430
2748
2.48
29.12
9.2
5.5
mmol/l
1.2
1.2
0.09
414
2459
(3026782) Osmolality of Urine
232
1181
2.45
25.35
3.2
2.8
mosm/kgh2o
514.4
547.1
1.56
204
1006
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
68
169
4.35
25.29
1.7
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
381
2431
2.26
24.16
22.7
9.7
e9/l
0.0
0.0
0.41
341
1994
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
150
4.44
23.84
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
382
2493
2.18
22.24
15.6
9.6
inr
1.2
1.3
2.69
171
684
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
46
94
5.17
21.62
1.8
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
26
9.94
21.55
1.2
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
106
402
2.93
20.57
4.7
2.8
g/l
9.9
10.7
0.79
97
364
(3000850) Epithelial cells [#/volume] in Urine
229
1251
2.24
20.51
3.2
2.6
e6/l
6.0
6.0
0.02
210
1103
(3019060) Gas panel - Arterial blood
106
410
2.87
19.82
4.9
4.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
326
2069
2.08
19.62
4.4
3.4
mmol/l
2.4
2.4
0.00
300
1778
(3035637) Corticotropin [Mass/volume] in Plasma
33
54
6.37
19.54
1.5
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
174
873
2.32
18.90
2.1
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
147
690
2.43
18.53
7.2
7.0
mmol/l
1.7
1.3
0.50
126
542
(36304419) Bacteria [Presence] in Urine
263
1576
2.08
18.14
3.7
3.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
58
166
3.72
17.71
1.5
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
268
1631
2.05
17.61
3.7
3.3
e6/l
0.3
0.5
1.43
233
1234
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
29
47
6.40
17.32
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
49
127
4.08
17.18
2.7
1.9
g/l
128.4
127.5
0.08
34
95
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
144
692
2.36
17.12
7.4
7.0
kpa
5.1
5.1
0.11
138
669
(40768795) Lymph node Pathology biopsy report
32
58
5.74
17.10
1.3
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
144
693
2.36
17.06
7.3
7.0
kpa
10.5
11.9
3.68
139
672
(46235355) HIV 1 and 2 tests - Meaningful Use set
128
594
2.42
16.41
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
190
3.42
16.40
3.5
2.4
u/ml
0.3
0.4
0.96
50
111
(3024561) Albumin [Mass/volume] in Serum or Plasma
376
2621
1.95
16.34
6.4
4.5
g/l
32.9
35.0
10.50
356
2432
(3017143) Hepatitis C virus Ab [Presence] in Serum
108
469
2.54
15.95
1.6
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
281
1790
1.96
15.82
3.7
2.3
u/l
54.5
56.9
0.50
261
1647
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
209
1200
2.06
15.80
2.7
1.6
mg/l
1.6
1.3
0.58
170
937
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
514
2.46
15.52
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
317
2116
1.92
15.41
3.9
3.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
83
323
2.78
15.22
2.7
1.6
g/l
1.3
1.6
0.35
75
290
(1617658) Protocol used for examination of sentinel lymph nodes
30
58
5.36
14.97
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
18
9.66
14.38
3.5
6.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
274
1776
1.90
14.30
3.9
3.4
e6/l
34.5
108.0
1.19
237
1379
(3013826) Glucose [Moles/volume] in Serum or Plasma
448
3393
1.90
14.29
8.4
4.6
mmol/l
6.7
6.7
0.43
431
3192
(3003458) Phosphate [Moles/volume] in Serum or Plasma
143
739
2.18
14.07
6.2
5.0
mmol/l
1.1
1.0
1.18
131
674
(3021879) Hepatitis B virus core Ab [Presence] in Serum
78
307
2.74
13.97
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
153
817
2.12
13.82
2.8
2.5
%
20.8
21.7
0.32
126
696
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
98
434
2.46
13.81
1.9
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
158
861
2.08
13.50
2.7
2.4
g/l
2.3
2.3
0.09
145
795
(3021901) Oxygen saturation in Capillary blood
40
107
3.91
13.43
2.9
2.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
542
4429
2.02
13.11
17.8
7.3
u/l
81.2
79.1
0.53
536
4128
(3037522) Nuclear Ab [Titer] in Serum
134
698
2.14
12.84
1.4
1.3
titre
189.7
538.0
5.08
35
162
(3020779) Urea [Moles/volume] in Serum or Plasma
107
509
2.30
12.80
9.8
6.5
mmol/l
10.8
10.1
0.34
102
483
(3022948) Iron [Moles/volume] in Serum or Plasma
167
945
2.01
12.80
2.8
2.4
umol/l
11.8
12.4
0.42
154
866
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
331
2340
1.79
12.59
5.7
3.9
ng/l
45.8
52.0
0.13
274
1735
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
56
4.98
12.47
2.0
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
45
5.49
12.37
1.8
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
110
538
2.24
12.30
3.8
2.7
g/l
64.8
66.4
1.35
97
481
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
287
1965
1.78
12.02
4.1
3.1
ng/l
1337.1
1505.9
0.43
263
1694
(3004588) Protein electrophoresis panel - Serum or Plasma
97
461
2.28
11.59
3.5
2.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
53
4.86
11.26
2.0
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
42
5.38
11.12
1.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
222
1436
1.80
11.08
13.5
6.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
119
3.41
10.83
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
119
3.41
10.83
1.7
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
253
1711
1.75
10.78
6.2
3.1
u/l
35.4
32.2
0.42
244
1617
(3018095) Leukocytes [#/volume] in Urine
292
2062
1.72
10.62
4.5
3.9
e6/l
56.3
116.2
0.91
250
1490
(3041096) Erythrocytes [Presence] in Urine by Automated
223
1461
1.78
10.57
4.7
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
80
364
2.35
10.55
3.6
3.2
mmol/l
3.8
1.9
4.72
62
278
(40768806) Pleura Pathology biopsy report
30
79
3.92
10.31
1.3
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
27
6.43
10.31
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
26
62
4.32
10.17
1.8
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
127
713
1.96
9.75
3.5
2.5
%
1.8
1.8
0.09
115
631
(3029937) Albumin [Presence] in Urine by Test strip
227
1524
1.73
9.73
5.4
4.3
estimate
0.0
0.0
0.00
125
502
(3009343) pH of Capillary blood
81
387
2.24
9.52
3.6
3.2
ph
7.4
7.4
1.75
27
44
(3018677) aPTT in Platelet poor plasma by Coagulation assay
153
929
1.83
9.19
2.7
1.9
s
30.6
29.5
1.27
146
891
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
24
6.37
9.02
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
43
4.76
8.87
1.5
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
539
2.00
8.58
4.7
3.1
ng/l
288.6
226.5
0.49
92
499
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
28
81
3.56
8.45
1.2
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
39
139
2.91
8.41
4.2
3.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
464
3836
1.63
8.23
6.4
4.8
e6/l
2444.3
3636.7
0.22
11
62
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
83
3.47
8.15
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
344
2.19
8.06
1.5
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
27
79
3.52
8.02
1.7
2.0
pg
30.0
31.9
1.13
27
79
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
106
3.12
7.83
1.3
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
284
2109
1.59
7.82
5.2
4.2
—
—
—
0
0
(3000492) Spirometry study
84
440
2.03
7.79
2.0
1.5
—
—
—
0
0
(4010399)
81
419
2.06
7.77
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
65
310
2.21
7.67
1.3
1.2
u/ml
551.4
264.8
0.55
59
272
(3023520) Reticulocytes [#/volume] in Blood
97
538
1.93
7.64
2.9
2.6
e9/l
68.5
70.7
0.27
81
417
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
18
6.77
7.62
1.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
54
239
2.37
7.59
1.3
2.2
u/l
44.9
38.9
0.54
47
210
(3013707) Erythrocyte sedimentation rate by Westergren method
491
4157
1.62
7.51
6.9
4.2
mm/h
21.4
13.5
13.46
468
3783
(3026008) Bacteria identified in Urine by Culture
263
1941
1.57
7.32
4.5
3.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
80
3.34
7.17
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
115
689
1.80
7.10
1.7
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
353
2794
1.54
7.10
5.0
4.0
estimate
0.0
0.0
0.50
128
510
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
76
3.37
7.03
1.2
1.2
u/ml
268.8
349.4
0.47
17
40
(3021601) Nitrite [Presence] in Urine by Test strip
348
2756
1.53
6.92
6.3
5.3
estimate
0.0
0.0
0.00
131
522
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
109
2.93
6.87
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
17
6.56
6.79
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
17
6.56
6.79
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
59
286
2.16
6.70
1.5
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
95
549
1.85
6.58
3.9
3.4
mmol/l
2.7
1.9
1.29
77
438
(3020891) Body temperature
53
248
2.23
6.57
4.7
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
80
3.20
6.50
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
344
2743
1.50
6.46
5.1
4.0
estimate
0.0
0.0
0.00
136
524
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
7
14.47
6.41
1.5
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
59
292
2.12
6.36
2.9
2.8
pmol/l
4.1
4.4
1.15
50
248
(3034860) Kappa light chains.free [Mass/volume] in Serum
44
193
2.37
6.33
5.0
3.4
mg/l
107.1
92.0
0.12
24
159
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
194
2.35
6.26
5.0
3.4
mg/l
60.9
45.1
0.26
24
160
(3000991) Gas panel - Venous blood
85
482
1.87
6.25
8.9
7.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
176
1222
1.59
6.20
3.6
3.0
mmol/l
2.5
2.5
3.31
161
1073
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
111
690
1.72
6.01
3.0
3.9
ug/l
6.6
27.3
1.08
91
577
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
60
306
2.05
5.99
10.4
9.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
101
2.85
5.96
1.7
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
6
15.17
5.91
1.3
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
131
2.59
5.87
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
299
2350
1.48
5.85
2.7
2.2
nmol/l
81.0
79.5
0.44
278
2057
(3012441) Differential panel - Pleural fluid
23
75
3.14
5.81
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
290
2268
1.48
5.80
2.4
2.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
40
176
2.35
5.73
6.1
5.8
mmol/l
1.4
1.3
0.08
35
158
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
116
2.66
5.62
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
456
3916
1.48
5.51
6.6
4.5
—
—
—
0
0
(3019977) pH of Arterial blood
13
30
4.40
5.31
2.7
4.7
ph
7.4
7.4
—
8
7
(3012544) pH of Venous blood
93
573
1.72
5.18
3.8
3.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
197
1454
1.50
5.14
3.7
2.7
umol/l
4732.2
7109.7
0.32
171
1227
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
76
2.96
5.07
3.0
3.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
56
3.27
4.92
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
56
3.27
4.92
1.8
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
56
3.27
4.92
1.8
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
33
143
2.37
4.92
1.9
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
765
0.48
4.88
4.2
4.7
%
31.4
32.7
0.31
27
481
(3001122) Ferritin [Mass/volume] in Serum or Plasma
286
2288
1.42
4.84
3.5
2.7
ug/l
188.4
132.4
2.43
268
2070
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
320
2612
1.42
4.83
5.3
4.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
32
138
2.38
4.82
3.6
2.1
g/l
3.7
3.7
0.08
32
132
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
33
4.00
4.73
3.9
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
504
5521
0.68
4.59
4.9
5.3
mmol/l
2.7
2.7
0.40
433
4999
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
52
279
1.93
4.54
4.3
3.4
mmol/l
25.3
24.3
1.06
46
254
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
90
571
1.66
4.50
2.3
2.1
g/l
0.2
0.2
0.71
85
534
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
176
1303
1.47
4.45
1.9
1.7
pmol/l
502.5
440.3
1.55
133
1050
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
72
2.83
4.32
1.4
1.3
e6/l
38750.1
123955.9
0.50
13
43
(3004451) EKG impression Narrative
12
31
3.92
4.27
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
390
3341
1.38
4.21
4.2
3.0
u/l
69.4
50.7
1.89
350
3063
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
198
1515
1.43
4.17
2.8
2.2
mg/l
3.5
3.1
1.06
178
1268
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
58
2.98
4.03
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
99
2.48
4.01
3.6
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
33
3.68
3.93
5.6
3.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
21
82
2.61
3.92
1.7
1.5
mu/l
303.0
283.9
0.13
21
74
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
494
5389
0.71
3.85
4.4
4.7
mmol/l
4.7
4.6
0.42
426
4913
(3007853) Bacteria identified in Skin by Aerobe culture
96
645
1.57
3.81
1.9
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
470
5165
0.72
3.80
3.9
4.1
mmol/l
1.3
1.3
1.48
398
4628
(3052592) Norovirus Ag [Presence] in Stool
7
8
8.82
3.78
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
290
1.82
3.77
2.1
1.8
g/l
1.6
1.5
0.14
39
255
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
93
622
1.57
3.77
3.6
2.6
umol/l
8.3
7.9
0.07
71
542
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
78
2.61
3.74
1.2
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
25
109
2.34
3.73
1.5
1.3
mmol/l
57.5
65.6
0.49
19
94
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
32
155
2.12
3.73
1.5
1.6
iu/ml
0.0
0.1
—
8
26
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
225
1791
1.38
3.70
2.4
2.1
u/l
144.8
208.1
1.37
213
1676
(3002256) Pathology report gross observation
104
719
1.53
3.63
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
491
5347
0.72
3.62
4.3
4.6
mmol/l
1.5
1.5
0.41
423
4834
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
29
137
2.17
3.60
2.9
2.9
mg/l
1.6
1.7
0.21
24
123
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
332
2824
1.34
3.50
3.2
2.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
20
81
2.51
3.49
1.4
1.3
e6/l
1254.5
1334.9
0.07
14
56
(3044889) 12 lead EKG panel
452
4027
1.35
3.46
6.3
4.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
14
5.77
3.35
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
223
1797
1.35
3.34
2.9
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
27
128
2.15
3.34
1.3
1.2
titre
153.3
71.0
—
6
10
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
499
5401
0.73
3.32
5.3
4.9
mmol/l
6.0
6.0
0.18
435
4842
(3052851) Hemolysis interference index of Serum or Plasma
32
163
2.01
3.29
4.2
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
33
171
1.98
3.24
1.4
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
66
2.62
3.23
1.6
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
100
1380
0.68
3.22
3.9
4.6
%
22.1
21.5
0.12
48
688
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
91
2.35
3.20
1.0
1.3
miu/ml
122.5
274.9
—
6
39
(3003694) ABO and Rh group [Type] in Blood
171
1331
1.38
3.17
1.6
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
44
2.99
3.15
1.9
2.5
ml
898.2
556.8
—
5
26
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
39
3.11
3.10
1.5
1.2
g/l
0.4
0.4
—
7
28
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
39
3.11
3.10
1.2
1.2
u/ml
5.1
1.0
—
7
23
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
39
3.11
3.10
1.5
1.2
g/l
2.2
2.9
—
7
29
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
39
3.11
3.10
1.5
1.2
g/l
5.0
7.1
—
7
29
(3007164) IgA [Mass/volume] in Serum or Plasma
134
1005
1.41
3.09
2.1
1.4
g/l
2.7
2.6
0.24
96
567
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
62
2.62
3.06
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
12
5.88
3.02
1.1
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
5
10.06
2.98
1.0
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
26
129
2.05
2.89
3.8
2.2
%
221.3
190.0
1.03
26
121
(4062490)
12
41
2.96
2.87
1.5
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
286
0.37
2.85
1.1
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
71
2.43
2.82
1.6
1.7
g/l
0.5
0.9
1.44
11
55
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
18
4.48
2.80
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
122
922
1.39
2.69
1.3
1.3
iu/ml
37.3
37.8
0.02
47
293
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
528
1.49
2.62
2.9
2.4
u/l
38.4
34.5
0.27
66
438
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
62
2.45
2.55
3.7
1.9
u/l
29.8
128.4
—
6
16
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
11
5.49
2.55
4.0
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
56
2.53
2.54
5.0
3.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
173
1.83
2.50
1.1
1.5
ug/g
285.2
275.2
0.09
20
102
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
26
3.49
2.49
1.2
1.3
%
2.9
4.2
—
9
19
(3019309) Folate [Moles/volume] in Red Blood Cells
154
1225
1.33
2.44
1.9
1.8
nmol/l
1320.5
1204.8
0.62
104
903
(3042733) HLA Ab [Presence] in Serum
5
8
6.29
2.37
3.6
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
81
586
1.43
2.29
1.8
2.1
ug/g
155.5
145.8
0.09
61
445
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
66
2.30
2.26
5.7
3.3
—
—
—
0
0
(3024471) HLA-A [Type]
5
9
5.59
2.21
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
9
5.59
2.21
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
54
2.43
2.21
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
114
883
1.35
2.16
1.2
1.3
u/ml
37.3
13.0
0.89
31
316
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
991
0.71
2.12
2.6
3.1
ug/l
0.9
0.8
0.36
49
669
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
67
476
1.45
2.10
4.0
3.4
ng/l
89.6
83.8
0.25
54
409
(3028433) Virus identified in Specimen by Culture
8
25
3.22
2.10
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
93
702
1.37
2.08
1.4
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
15
4.03
2.04
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
15
4.03
2.04
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
32
2.84
2.00
3.0
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
388
1.48
2.00
2.0
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
25
142
1.79
1.95
1.3
1.2
titre
—
760.0
—
0
6
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
11
4.57
1.94
1.4
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
27
2.98
1.94
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
145
1181
1.29
1.93
5.6
4.0
ng/l
443.5
315.8
0.17
127
964
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
121
1.84
1.90
1.1
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
486
5167
0.80
1.89
6.4
6.2
mmol/mol
41.3
40.3
1.30
430
4722
(3013512) EKG study
214
1831
1.24
1.88
5.0
4.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
22
3.20
1.88
2.6
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
2.6
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
2.6
1.7
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
5
12
4.19
1.82
1.4
1.4
%
2.4
2.8
—
5
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
23
3.06
1.80
2.6
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
455
4225
1.22
1.75
5.2
4.0
pmol/l
15.2
15.0
0.60
406
3770
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
18
3.35
1.75
3.0
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
573
5459
1.28
1.73
36.2
15.5
mg/l
25.9
24.8
0.34
543
4383
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
8
30
2.69
1.73
1.3
1.3
%
80.8
63.8
—
8
19
(1761868) Lipid panel - Serum or Plasma
194
1662
1.23
1.67
3.5
3.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
2.4
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
2.4
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
2.4
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
2.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
46
320
1.47
1.64
2.5
2.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
56
2.16
1.62
1.8
1.7
u/field
3.0
2.2
—
6
22
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
14
3.59
1.62
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
84
1.93
1.61
1.6
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
70
2.02
1.60
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
32
2.52
1.60
1.8
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
26
2.71
1.58
1.6
1.1
u/l
62.6
90.9
—
7
20
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
240
1.53
1.58
6.7
2.0
g/l
10.2
10.3
0.04
31
205
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
71
1.99
1.55
1.1
1.1
g/l
1.5
1.6
0.53
14
62
(40768797) Stomach Pathology biopsy report
100
801
1.29
1.52
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
57
761
0.73
1.52
14.1
7.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
51
2.18
1.51
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
146
1721
0.81
1.50
4.6
5.4
ug/l
3.6
3.2
0.12
123
1519
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
124
1.72
1.48
1.5
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
38
2.39
1.46
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
288
1.45
1.42
4.1
3.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
247
1.48
1.40
3.2
3.3
u/ml
309.9
1316.0
0.73
28
214
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
40
2.27
1.40
2.7
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
211
0.51
1.40
1.5
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
29
2.43
1.39
1.0
1.1
—
—
—
0
0
(4211845)
7
29
2.43
1.39
2.6
3.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
256
1.47
1.39
6.5
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
256
1.47
1.39
6.5
1.9
g/l
3.8
3.7
0.14
26
187
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
256
1.47
1.39
6.5
1.9
g/l
7.4
7.4
0.06
26
193
(3022145) Colonoscopy Study observation
79
622
1.30
1.38
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
32
215
1.51
1.38
7.5
2.2
g/l
1.4
0.9
0.32
25
187
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
19
112
1.72
1.36
1.3
1.2
u/l
92.1
28.7
0.67
14
97
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
75
1.88
1.35
1.8
1.6
%
46.9
65.4
—
9
51
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
24
2.51
1.30
1.3
1.2
%
4.9
35.2
—
6
19
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
24
2.51
1.30
2.3
1.9
ug/l
37.3
56.5
—
6
24
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
1.6
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
1.6
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
186
1.53
1.28
1.4
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
578
5973
0.81
1.28
48.6
23.0
e12/l
4.2
4.4
20.22
570
5785
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
266
0.59
1.27
2.6
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
578
5972
0.81
1.27
48.4
22.9
pg
30.3
30.4
0.21
572
5865
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
116
0.43
1.26
1.4
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
578
5971
0.81
1.26
48.5
22.9
fl
92.3
91.5
3.34
572
5865
(3007461) Platelets [#/volume] in Blood
578
5970
0.81
1.24
48.9
23.0
e9/l
256.9
245.5
3.31
570
5800
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
25
2.41
1.24
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
239
0.58
1.23
2.6
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
579
5974
0.82
1.19
48.6
23.0
e9/l
7.3
6.7
7.98
571
5786
(3006462) Nitrate [Presence] in Urine
6
26
2.32
1.19
2.7
3.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
26
2.32
1.19
2.3
2.8
u/ml
1190.5
1356.0
—
6
26
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
186
0.53
1.18
1.8
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
141
1.58
1.18
1.7
2.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
50
2.01
1.17
1.4
2.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
39
2.06
1.15
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
153
0.52
1.15
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
96
1.68
1.11
1.9
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
41
1.96
1.09
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
41
1.96
1.09
1.3
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
25
169
1.50
1.08
1.6
1.4
g/l
0.2
0.2
0.38
25
158
(3035320) C reactive protein [Mass/volume] in Body fluid
7
33
2.13
1.05
1.3
2.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
46
1.97
1.04
1.6
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
322
0.67
1.04
1.6
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
47
1.93
1.02
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
48
615
0.76
1.02
5.5
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
34
249
1.38
0.99
2.0
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
49
1.85
0.99
3.1
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
173
1.46
0.99
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
30
0.00
0.97
0.0
1.0
—
1.1
—
0
18
(3044242) Glucose [Moles/volume] in Arterial blood
7
36
1.95
0.97
3.0
3.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
36
1.95
0.97
1.1
2.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
174
1.45
0.96
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
117
1010
1.19
0.94
3.4
2.9
e6/l
0.7
1.1
1.59
73
574
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
176
1.44
0.92
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
238
1.36
0.87
7.3
2.0
g/l
3.2
3.1
0.23
26
189
(21494890) Protein electrophoresis panel - 24 hour Urine
10
58
1.73
0.80
2.2
2.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
48
1.67
0.79
1.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
139
1553
0.87
0.77
1.7
1.6
mmol/l
1.5
1.3
0.91
104
1280
(3012516) Albumin [Mass/volume] in Urine
164
1811
0.88
0.77
3.3
3.1
mg/l
887.4
227.2
0.56
98
1107
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
34
1.77
0.76
3.5
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
451
1.24
0.76
1.8
1.5
%
1.5
1.5
0.21
43
384
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
141
1.43
0.75
3.0
2.6
ug/min
54.2
85.6
0.48
11
85
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
108
947
1.17
0.74
3.6
3.2
e6/l
1.6
2.3
0.88
66
514
(3002523) Influenza virus A Ag [Presence] in Specimen
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
25
2.01
0.73
2.6
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
35
273
1.30
0.72
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
7
39
1.80
0.72
1.6
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
152
1370
1.14
0.72
2.9
2.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
41
1.71
0.70
1.3
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
7
41
1.71
0.70
1.3
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
41
1.71
0.70
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
41
1.71
0.70
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
169
0.65
0.69
1.6
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
77
1.57
0.69
2.7
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.0
—
8.1
—
0
8
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
59
1.53
0.68
2.7
2.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
167
1525
1.13
0.65
1.7
1.6
nmol/l
19.9
21.3
0.63
149
1273
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
169
1841
0.89
0.63
3.3
3.1
mmol/l
6.2
7.0
1.97
126
1512
(3020682) Albumin/Creatinine [Ratio] in Urine
176
1906
0.90
0.60
4.5
3.9
mg/mmol
8.0
7.6
0.05
94
1149
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
310
0.77
0.60
3.7
2.9
e6/l
0.0
0.3
2.91
24
302
(3009542) Hematocrit [Volume Fraction] of Blood
493
4779
1.11
0.59
31.4
17.0
%
37.4
38.9
2.26
279
3126
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
2.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
36
1.67
0.56
1.0
1.0
mg/l
377.0
293.0
—
6
30
(4281824)
11
73
1.52
0.56
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
37
1.63
0.55
1.5
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
116
1.39
0.55
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
62
536
1.17
0.54
1.6
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
98
0.61
0.52
1.5
2.0
nmol/l
31.7
44.1
—
6
92
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
463
1.18
0.52
7.4
2.8
ml/min/173m2
59.2
61.6
0.27
24
186
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
40
1.50
0.51
1.5
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
40
1.50
0.51
4.7
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
40
1.50
0.51
1.5
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
569
5798
0.90
0.49
23.1
10.8
u/l
24.8
24.6
0.19
562
5570
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
47
1.49
0.47
1.1
1.5
u/l
39.9
33.2
—
7
39
(4268621)
7
48
1.46
0.47
2.3
2.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
51
1.38
0.44
1.0
1.3
u/l
9.1
12.1
—
7
44
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
249
1.21
0.42
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
483
1.15
0.42
4.5
3.5
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
27.2
—
0
10
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.8
—
2.2
—
0
7
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
60
1.34
0.40
1.8
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
35
1.43
0.39
4.2
2.8
%
13.5
13.3
—
5
35
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
160
1.26
0.39
1.9
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
72
1.39
0.37
2.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
81
1.36
0.36
1.1
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
76
0.66
0.36
2.4
2.1
pmol/l
210.0
221.3
—
5
70
(4034850)
14
176
0.79
0.32
9.2
10.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
92
1.31
0.32
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
174
1.21
0.32
2.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
62
1.29
0.28
1.5
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
299
1.14
0.28
2.4
2.2
nmol/l
8.8
12.7
2.38
29
252
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
36
318
1.14
0.28
1.3
1.2
iu/ml
142.4
155.4
—
9
115
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
150
1.21
0.26
1.7
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
123
1.22
0.25
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
234
0.85
0.25
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
137
0.80
0.24
1.3
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
39
1.28
0.23
2.6
3.7
u/ml
—
31.4
—
0
12
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
43
391
1.11
0.22
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
115
1210
0.94
0.22
6.0
4.5
kg/l
1.0
1.0
0.24
16
176
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
8.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
387
0.90
0.21
3.7
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
512
5184
0.95
0.20
33.0
14.7
ml/min/173m2
75.1
75.6
0.21
480
4262
(3023103) Potassium [Moles/volume] in Serum or Plasma
571
5764
0.95
0.19
35.5
18.4
mmol/l
4.0
4.0
0.45
559
5591
(3019550) Sodium [Moles/volume] in Serum or Plasma
570
5751
0.95
0.18
35.1
18.3
mmol/l
139.0
139.7
7.02
558
5583
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
763
0.94
0.18
1.4
1.4
—
—
—
0
0
(4306422)
7
61
1.15
0.17
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
68
1.18
0.16
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
246
0.89
0.16
3.1
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
19
214
0.88
0.16
1.1
1.1
titre
—
32.2
—
0
5
(1002224) Polysomnography panel
19
168
1.13
0.16
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
213
0.89
0.15
2.6
2.9
g/l
0.1
0.2
1.21
11
76
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
83
1.09
0.14
2.7
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
285
1.09
0.14
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
84
1.19
0.14
1.5
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
85
1.18
0.12
2.5
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
153
1.11
0.11
1.8
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
135
0.89
0.10
3.3
2.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
135
0.89
0.10
1.8
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
242
1.08
0.09
2.8
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
87
1.15
0.09
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
57
1.05
0.08
3.8
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
61
0.82
0.08
1.0
1.1
—
163.1
—
0
12
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
65
0.77
0.08
1.6
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
75
1.07
0.07
1.3
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
111
0.90
0.06
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
366
1.04
0.05
4.8
3.2
e9/l
5.0
4.0
1.00
29
259
(40761511) CBC panel - Blood by Automated count
564
5620
1.02
0.05
32.4
14.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
130
1318
0.98
0.04
5.0
4.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
91
1.10
0.04
2.6
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
253
2547
0.99
0.03
2.0
2.1
pmol/l
93.0
94.0
0.13
129
1265
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
219
0.96
0.03
2.1
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
301
1.03
0.02
4.7
4.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
228
0.96
0.02
1.4
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
104
1.06
0.01
4.3
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
508
5073
1.01
0.00
6.0
4.9
mu/l
2.1
2.2
0.26
456
4541
(1761482) Bacteria [#/volume] in Urine by Culture
17
164
1.04
0.00
5.4
5.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
334
1.02
0.00
1.3
1.3
—
—
—
0
0
(4094501)
15
147
1.02
0.00
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
112
1123
1.00
0.00
1.3
1.2
u/ml
0.5
1.6
2.35
22
273
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
10.8
—
0
6
(3028300) Cannabinoids [Presence] in Urine
7
75
0.93
0.00
3.6
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.6
—
17.1
—
0
9
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
75
0.93
0.00
3.6
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
36.3
—
0
9
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
74
0.95
0.00
3.6
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
70
1.00
0.00
3.6
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
73
0.96
0.00
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
77.9
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
68
0.88
0.00
1.5
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
73
0.96
0.00
3.6
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
81.2
—
0
9
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
20.8
—
0
9
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3011648) Oxygen content in Venous blood
5
50
1.00
0.00
1.0
1.6
%
13.4
10.1
—
5
50
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_RESPCONDEXT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_RESPCONDEXT | 2.553 [2.22, 2.94] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.283 |
During the follow-up period (1.1.1998 — 31.12.2019), 1081 out of 2197 females with J10_RESPCONDEXT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_RESPCONDEXT | 4.277 [3.44, 5.32] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 953 out of 1460 males with J10_RESPCONDEXT died.
Mortality risk
Mortality risk for people of age
years, who have J10_RESPCONDEXT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.267% | 0.724% |
| 5 | 1.56% | 4.682% |
| 10 | 3.869% | 11.389% |
| 15 | 6.993% | 21.879% |
| 20 | 12.541% | 33.517% |
Relationships between endpoints
↥Index endpoint: J10_RESPCONDEXT – Respiratory conditions due to other external agents
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data